Related Experiment Videos
Author's Reply: Does increased 11 β HSD-1 activity induce adverse metabolic phenotype only in lean?
Rachel K Crowley1, Conor P Woods2, Jeremy W Tomlinson3
1Department of Endocrinology, St.Vincent's University Hospital, Dublin, Ireland.
Clinical Endocrinology
|March 5, 2019
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.
The lancet. Gastroenterology & hepatology·2026
Adiposity rebound and height velocity in patients with congenital adrenal hyperplasia.
European journal of endocrinology·2026
Hormone Replacement Therapy for Menopausal Symptoms and the Risk of Cardiometabolic Disease: Current Evidence and Future Directions.
BJOG : an international journal of obstetrics and gynaecology·2026
Approach to The Patient With Combined Pituitary Hormone Deficiency Due to a Novel Homozygous LHX3 Variant.
Clinical endocrinology·2026
Parathyroid Carcinoma Revisited: Clinical and Pathological Insights From Two Decades of Experience.
Clinical endocrinology·2026
HMGA2 is a highly sensitive marker for DICER1-related tumours.
Histopathology·2026
Correction: Generation and characterization of germline-specific autophagy and mitochondrial reactive oxygen species reporters in Drosophila.
Frontiers in cell and developmental biology·2026